Sodium alendronate: proposal and reliability of indicators
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
DOI: | 10.1590/s2175-97902022e19193 |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/204496 |
Resumo: | The present study proposes and evaluates the test-retest reliability of indicators of the correct use of sodium alendronate in elderly patients. This is a test-retest reliability study for use of sodium alendronate. Six questions to evaluate the correct use of this medicine were elaborated after analysis of information in the literature. Data collection was performed through questionnaires in face-to-face in-home interviews by previously trained interviewers. The participants were initially interviewed (test) when they agreed to participate in the study, and secondly (retest), after a period of 7 to 14 days from the first interview. The reliability of the questions was evaluated by means of the agreement percentage and the Kappa coefficient. Fifty-seven pairs (test-retest) were obtained. The mean age was 69.3 (SD = 6.9) years, the majority (92.5%) completed elementary education, and declared themselves white (50.9%). All the questions presented high concordance ranging from 79.0% to 98.3%. The Kappa values ranged from 0.1 (low) to 0.83 (very good). The agreement percentage and the Kappa values suggest adequate reliability of the proposed questions. We suggest that they can be used as a simple and quick way to evaluate the quality of sodium alendronate use among the elderly. |
id |
USP-31_f4275912c23446c513973b783c6be832 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/204496 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
spelling |
Sodium alendronate: proposal and reliability of indicatorsDrug utilizationAlendronateOsteoporosis PostmenopausalThe present study proposes and evaluates the test-retest reliability of indicators of the correct use of sodium alendronate in elderly patients. This is a test-retest reliability study for use of sodium alendronate. Six questions to evaluate the correct use of this medicine were elaborated after analysis of information in the literature. Data collection was performed through questionnaires in face-to-face in-home interviews by previously trained interviewers. The participants were initially interviewed (test) when they agreed to participate in the study, and secondly (retest), after a period of 7 to 14 days from the first interview. The reliability of the questions was evaluated by means of the agreement percentage and the Kappa coefficient. Fifty-seven pairs (test-retest) were obtained. The mean age was 69.3 (SD = 6.9) years, the majority (92.5%) completed elementary education, and declared themselves white (50.9%). All the questions presented high concordance ranging from 79.0% to 98.3%. The Kappa values ranged from 0.1 (low) to 0.83 (very good). The agreement percentage and the Kappa values suggest adequate reliability of the proposed questions. We suggest that they can be used as a simple and quick way to evaluate the quality of sodium alendronate use among the elderly.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-11-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20449610.1590/s2175-97902022e19193Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/204496/194963Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Ricardo Augusto dos SantosBaldoni, Andre OliveiraAlvim, Camila PereiraObreli-Neto, Paulo RoqueGuidoni, Camilo MolinoSilva, Isabella RibeiroFigueiredo, Roberta Carvalho 2023-08-18T20:55:25Zoai:revistas.usp.br:article/204496Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-08-18T20:55:25Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Sodium alendronate: proposal and reliability of indicators |
title |
Sodium alendronate: proposal and reliability of indicators |
spellingShingle |
Sodium alendronate: proposal and reliability of indicators Sodium alendronate: proposal and reliability of indicators Silva, Ricardo Augusto dos Santos Drug utilization Alendronate Osteoporosis Postmenopausal Silva, Ricardo Augusto dos Santos Drug utilization Alendronate Osteoporosis Postmenopausal |
title_short |
Sodium alendronate: proposal and reliability of indicators |
title_full |
Sodium alendronate: proposal and reliability of indicators |
title_fullStr |
Sodium alendronate: proposal and reliability of indicators Sodium alendronate: proposal and reliability of indicators |
title_full_unstemmed |
Sodium alendronate: proposal and reliability of indicators Sodium alendronate: proposal and reliability of indicators |
title_sort |
Sodium alendronate: proposal and reliability of indicators |
author |
Silva, Ricardo Augusto dos Santos |
author_facet |
Silva, Ricardo Augusto dos Santos Silva, Ricardo Augusto dos Santos Baldoni, Andre Oliveira Alvim, Camila Pereira Obreli-Neto, Paulo Roque Guidoni, Camilo Molino Silva, Isabella Ribeiro Figueiredo, Roberta Carvalho Baldoni, Andre Oliveira Alvim, Camila Pereira Obreli-Neto, Paulo Roque Guidoni, Camilo Molino Silva, Isabella Ribeiro Figueiredo, Roberta Carvalho |
author_role |
author |
author2 |
Baldoni, Andre Oliveira Alvim, Camila Pereira Obreli-Neto, Paulo Roque Guidoni, Camilo Molino Silva, Isabella Ribeiro Figueiredo, Roberta Carvalho |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Silva, Ricardo Augusto dos Santos Baldoni, Andre Oliveira Alvim, Camila Pereira Obreli-Neto, Paulo Roque Guidoni, Camilo Molino Silva, Isabella Ribeiro Figueiredo, Roberta Carvalho |
dc.subject.por.fl_str_mv |
Drug utilization Alendronate Osteoporosis Postmenopausal |
topic |
Drug utilization Alendronate Osteoporosis Postmenopausal |
description |
The present study proposes and evaluates the test-retest reliability of indicators of the correct use of sodium alendronate in elderly patients. This is a test-retest reliability study for use of sodium alendronate. Six questions to evaluate the correct use of this medicine were elaborated after analysis of information in the literature. Data collection was performed through questionnaires in face-to-face in-home interviews by previously trained interviewers. The participants were initially interviewed (test) when they agreed to participate in the study, and secondly (retest), after a period of 7 to 14 days from the first interview. The reliability of the questions was evaluated by means of the agreement percentage and the Kappa coefficient. Fifty-seven pairs (test-retest) were obtained. The mean age was 69.3 (SD = 6.9) years, the majority (92.5%) completed elementary education, and declared themselves white (50.9%). All the questions presented high concordance ranging from 79.0% to 98.3%. The Kappa values ranged from 0.1 (low) to 0.83 (very good). The agreement percentage and the Kappa values suggest adequate reliability of the proposed questions. We suggest that they can be used as a simple and quick way to evaluate the quality of sodium alendronate use among the elderly. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11-17 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/204496 10.1590/s2175-97902022e19193 |
url |
https://www.revistas.usp.br/bjps/article/view/204496 |
identifier_str_mv |
10.1590/s2175-97902022e19193 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/204496/194963 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1822179249489969152 |
dc.identifier.doi.none.fl_str_mv |
10.1590/s2175-97902022e19193 |